ArticleExperimental biology and medicine (Maywood, N.J.)2022
Iron-based phosphorus chelator: Risk of iron deposition and action on bone metabolism in uremic rats.
Wander Barros do Carmo, Bárbara Bruna Abreu Castro, Luísa Cardoso Manso, Priscylla Aparecida Vieira do Carmo, Clóvis Antônio Rodrigues, Melani Ribeiro Custódio, Vanda Jorgetti, Helady Sanders-Pinheiro
Open access · greenAbstract read
In one paragraphArticle in Experimental biology and medicine (Maywood, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 79% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 3 institutions in 1 country.
Wander Barros do CarmoLaboratory of Experimental Nephrology (LABNEX), Interdisciplinary Nucleus of Laboratory Animal Studies (NIDEAL), Center for Reproductive Biology (CBR), 28113Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil.
Bárbara Bruna Abreu CastroLaboratory of Experimental Nephrology (LABNEX), Interdisciplinary Nucleus of Laboratory Animal Studies (NIDEAL), Center for Reproductive Biology (CBR), 28113Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil.
Luísa Cardoso MansoLaboratory of Experimental Nephrology (LABNEX), Interdisciplinary Nucleus of Laboratory Animal Studies (NIDEAL), Center for Reproductive Biology (CBR), 28113Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil.
Priscylla Aparecida Vieira do CarmoDepartment of Internal Medicine, School of Medicine, 28113Federal University of Juiz de Fora, Juiz de Fora 36038-330, Brazil.
Clóvis Antônio RodriguesNucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale do Itajaí, Itajaí 88302-202, Brazil.
Melani Ribeiro CustódioLaboratory of Renal Physiopathology, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Vanda JorgettiLaboratory of Renal Physiopathology, School of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.
Helady Sanders-PinheiroLaboratory of Experimental Nephrology (LABNEX), Interdisciplinary Nucleus of Laboratory Animal Studies (NIDEAL), Center for Reproductive Biology (CBR), 28113Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil.ORCID 0000-0001-8603-1331 Universidade Federal de Juiz de Fora · BRUniversidade de São Paulo · BRUniversidade do Vale do Itajaí · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Phosphate chelators are frequently used in patients with chronic kidney disease (CKD). New iron-based chelators remain understudied and offer a promising therapeutic option for the control of bone and mineral disorders of chronic kidney disease (BMD-CKD). We assessed the effect of the phosphorus chelator, chitosan-iron III (CH-FeCl), compared to calcium carbonate (CaCO
Indexed as
Bone and BonesChelating AgentsPhosphorusRenal Insufficiency, ChronicAnimalsFibroblast Growth FactorsIronParathyroid HormonePhosphatesRatsChelating AgentsFibroblast Growth FactorsIronParathyroid HormonePhosphatesPhosphoruschitosanchronicchronic kidney disease-mineral and bone disorderfibroblast growth factor 23Hyperphosphatemiairon overloadrenal insufficiency
Identifiers
PMID34861126
PMCPMC8919316
OpenAlexW3217178400
What OpenQuestion holds
Textmetadata
Read underepoch 390